Insulin degludec/insulin aspart
id:
insulin-degludec-insulin-aspart-172-19148575
title:
Insulin degludec/insulin aspart
text:
Insulin degludec/insulin aspart, sold under the brand name Ryzodeg, is a fixed-dose combination medication for the treatment of diabetes mellitus. It contains insulin degludec and insulin aspart. It is given as an injection under the skin in the abdominal wall, upper arm or thigh. The most frequently reported side effect is hypoglycemia. It was approved for medical use in the European Union in January 2013, and in Australia in November 2017.
brand slug:
wiki
category slug:
encyclopedia
description:
Combination medication
original url:
https://en.wikipedia.org/wiki/Insulin_degludec/insulin_aspart
date created:
2020-07-19T01:05:27Z
date modified:
2024-09-02T04:03:57Z
main entity:
{"identifier":"Q97574470","url":"https://www.wikidata.org/entity/Q97574470"}
image:
fields total:
13
integrity:
15